Kronox Lab Sciences Limited share price

Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, and custom specification. Kronox Lab Sciences Limited was incorporated in 2008 and is based in Vadodara, India. As of September 29, 2026, Kronox Lab Scien…Read more

Website NSE BSE

Basic MaterialsSpecialty ChemicalsNSE: KRONOXISIN INE0ATZ01017

16 Oct 2026, 3:29 PM IST₹209.15▼ 9.03 (4.14%)

Market Cap₹ 776 Cr.
Current Price₹ 209.15
High / Low₹ 228 / 96
Stock P/E27.1
Book Value₹ 32
Dividend Yield0.23 %
ROCE31.9 %
ROE26.80 %
Face Value₹ 10.0

More figures (10)

EPS (TTM)₹ 7.73
Price / Book6.61
OPM32.3 %
Debt / Equity0.01
Sales growth (4Y)1.9 %
Profit growth (4Y)18.5 %
Promoter holding11.7 %
EV / EBITDA20.2
Beta0.89
All-time high₹ 229

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
KRONOX	+21.93%	+39.02%	+57.56%	+49.67%	+40.59%	—	—
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Kronox Lab Sciences Limited is in the Specialty Chemicals industry (Basic Materials), with a market value of ₹776 crore.
It trades at 27.1 times its last 12 months' earnings and 6.6 times book value.
Revenue grew 1.9% a year over the last 4 years, profit 18.5% a year.
Return on equity was 26.8% and return on capital employed 31.9% in the latest year.
Debt was 0.01 times shareholders' equity.
The share price is 8.2% below its 52-week high and up 40.6% over one year.
Promoters and insiders hold about 11.7%; institutions about 0.0%.

Pros

Strong return on equity: 32.6% on average over the last 3 years.
Company is almost debt-free (debt is 0.01 times equity).
Latest quarter (Jun 2026): sales up 17% and profit up 16% from a year ago.
Promoters hold a large stake of 74.21%.

Cons

Institutional (FII + DII) holding has fallen by 4.9 points over 9 quarters.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Kronox Lab Sciences Limited

Head office: Vadodara

Peer comparison

Company	Market cap (₹ Cr)	P/E	P/B	ROE	OPM	Sales CAGR	Div. yield
Kronox Lab Sciences LimitedKRONOX	776	27.1	6.61	26.8%	32.3%	+1.9%	0.23%
Acutaas Chemicals LimitedACUTAAS	26,248	68.2	15.88	24.0%	33.5%	+29.4%	0.08%
Polyplex Corporation LimitedPOLYPLEX	3,259	20.2	0.74	1.1%	2.1%	-2.5%	0.20%
Poddar Pigments LimitedPODDARMENT	281	18.5	0.80	4.1%	5.6%	+3.4%	1.48%

Companies in the same industry (Specialty Chemicals). Tap a heading to sort. Sorting is a way to explore data, not a recommendation.

Quarterly Results

Standalone figures in ₹ crore

₹ Cr	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	22	25	25	24	26	24	26	25	26	28
YOY Sales Growth %					17.83%	-3.60%	2.71%	5.26%	-0.02%	16.88%
	14	17	16	16	18	16	17	17	17	19
Material Cost %	47%	53%	45%	49%	55%	48%	45%	47%	45%	49%
Employee Cost %	5%	5%	5%	5%	5%	7%	7%	8%	6%	7%
Other Expenses %	12%	10%	14%	11%	11%	11%	14%	13%	12%	12%
Operating Profit	8	8	9	8	8	8	9	8	10	9
OPM %	35%	33%	35%	35%	30%	33%	34%	32%	36%	32%
Other Income	1	0	0	1	1	1	1	1	2	1
Interest							0	0	0	0
Depreciation	0	0	0	0	0	0	0	1	1	0
Profit before tax	8	8	9	9	8	8	9	9	11	10
	30%	26%	27%	26%	24%	26%	27%	23%	27%	26%
Current tax	2	2	2	2	2	2	3	2	3	3
Deferred tax	0	-0	0	0	-0	-0	0	-0	0	-0
	6	6	6	7	6	6	7	7	8	7
YOY Profit Growth %					7.36%	2.09%	3.14%	0.93%	26.71%	16.31%
EPS in Rs	1.60	1.67	1.76	1.77	1.72	1.70	1.82	1.79	2.18	2.00
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Standalone figures in ₹ crore

₹ Cr	Mar 2024	Mar 2025	Mar 2026	TTM
	90	100	101	105
YOY Sales Growth %		11.50%	1.02%
	62	67	67	70
Material Cost %	51%	51%	46%	46%
Employee Cost %	7%	5%	7%	7%
Other Expenses %	11%	11%	13%	13%
Operating Profit	28	33	34	35
OPM %	32%	33%	34%	33%
Other Income	2	3	5	6
Interest			0	0
Depreciation	1	1	2	2
Profit before tax	29	34	37	39
	25%	26%	26%	26%
Current tax	7	9	10
Deferred tax	-0	0	-0
	21	25	28	29
YOY Profit Growth %		18.53%	9.29%
EPS in Rs	5.81	6.91	7.51	7.79
Dividend Payout %		7%	7%

Compounded Sales Growth

TTM:: 6%

Compounded Profit Growth

TTM:: 12%

Stock Price CAGR

1 Year:: 41%

Return on Equity

4 Years:: 34%
Last Year:: 27%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	37	37	37	37
Reserves	8	29	53	79
				2
Long term borrowings				1
Short term borrowings				1
	9	8	9	10
Trade payables	8	6	7	7
Current liabilities	9	8	9	10
Total Liabilities	54	74	99	128
	16	27	29	30
Gross block	26	38	41	44
Accumulated depreciation	10	11	12	14
CWIP		0	1	1
	38	47	69	97
Inventories	9	9	6	8
Trade receivables	19	18	20	21
Cash & equivalents	2	3	3	3
Current assets	34	47	63	79
Total Assets	54	74	99	128

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	20	17	31	24
Profit for the year	17	21	25	28
Working capital changes	2	-4	5	-2
Direct taxes paid	-6	-7	-9	-10
	-6	-17	-28	-24
Fixed assets purchased	-8	-12	-3	-3
Fixed assets sold	0			0
Investments sold	2
	-13		-2	-0
Proceeds from borrowings				2
Interest paid	-0			-0
Dividends paid			-2	-2
Net Cash Flow	1	0	0	-0
Free Cash Flow	11	5	28	21

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	—	37.2%	38.5%	32.6%	26.8%
ROCE	—	49.6%	43.1%	38.0%	31.9%
Operating margin	—	21.4%	30.5%	32.1%	32.3%
Net margin	—	17.4%	23.8%	25.4%	27.3%
Debt / equity	—	0.00	—	0.00	0.01
Current ratio	—	3.85	6.07	7.28	7.60

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities).

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 74.21%
FIIs 0.04%
DIIs 2.07%
Public 23.67%

%	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%
	1.56%	0.55%	0.48%	0.04%	0.03%	0.03%	0.05%	0.08%	0.04%
Foreign portfolio investors (Cat. I)	1.56%	0.50%	0.46%	0.02%	0.03%	0.03%	0.05%	0.08%	0.04%
Foreign portfolio investors (Cat. II)		0.06%	0.03%	0.03%
	5.43%	2.57%	2.20%	2.20%	1.71%	1.93%	2.00%	2.05%	2.07%
Insurance companies	0.03%
Alternative investment funds	4.31%	2.57%	2.20%	2.20%	1.71%	1.93%	2.00%	2.05%	2.07%
	18.80%	22.67%	23.10%	23.55%	24.05%	23.83%	23.75%	23.66%	23.67%
Retail (up to ₹2 lakh)	14.86%	18.92%	18.70%	18.57%	19.37%	18.78%	19.14%	18.97%	18.98%
HNIs (above ₹2 lakh)	1.40%	1.66%	1.50%	1.97%	2.03%	2.42%	1.98%	2.01%	1.84%
NRIs	0.16%	0.33%	0.65%	0.67%	0.70%	0.70%	0.70%	0.83%	1.02%
Bodies corporate	1.56%	0.84%	1.23%	1.47%	1.10%	1.06%	0.93%	0.82%	0.84%
No. of Shareholders	32,604	39,792	38,489	37,922	37,569	35,780	34,608	33,469	32,479

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

None filed recently.

Concalls & investor meets

None filed recently.

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date: 9 Sep 2026
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Questions about Kronox Lab Sciences Limited

What is the share price of Kronox Lab Sciences Limited today?

Kronox Lab Sciences Limited (KRONOX) last traded at ₹209.15 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.

What is the market cap of Kronox Lab Sciences Limited?

About ₹776 crore at the latest price.

What is the P/E ratio of Kronox Lab Sciences Limited?

About 27.1 times its earnings over the last 12 months.

Is Kronox Lab Sciences Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Kronox Lab Sciences Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.